Bangkok Lab And Cosmetic

BLC

THB407010008

Pharmaceuticals

End-of-day quote Thailand S.E. Other stock markets 03:30:00 01/07/2024 am IST			5-day change	1st Jan Change
4.78 ^THB	-0.42%		+1.70%	+3.91%

21/06	Certain Shares of Bangkok Lab And Cosmetic Public Company Limited are subject to a Lock-Up Agreement Ending on 21-JUN-2024.	CI
13/05	Bangkok Lab And Cosmetic Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Bangkok Lab and Cosmetic Public Company Limited Declares Cash Dividend Payment for the Operating Period from 01 January 2023 to 30 June 2023, Payable on 14 September 2023

August 15, 2023 at 06:17 am IST

Bangkok Lab And Cosmetic Public Company Limited declared Cash dividend payment THB 0.03 for the Operating period from 01-January-2023 to 30-June-2023 Record date for the right to receive dividend: 29-August-2023, Ex-dividend date: 28-August-2023 and Payment date: 14-September-2023.

Latest news about Bangkok Lab And Cosmetic

Certain Shares of Bangkok Lab And Cosmetic Public Company Limited are subject to a Lock-Up Agreement Ending on 21-JUN-2024.	21/06	CI
Bangkok Lab And Cosmetic Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05	CI
Bangkok Lab And Cosmetic Public Company Limited Approves Final Dividend for the Year 2023, Payable on April 30, 2024	01/04	CI
Bangkok Lab and Cosmetic Public Company Limited Proposes the Dividend Payment for the Year 2023, Payable on April 30, 2024	29/02	CI
Bangkok Lab And Cosmetic Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI
Bangkok Lab and Cosmetic Public Company Limited Announces Changing of Chief Accountant	01/02	CI
Certain Shares of Bangkok Lab And Cosmetic Public Company Limited are subject to a Lock-Up Agreement Ending on 21-DEC-2023.	21/12	CI
Bangkok Lab And Cosmetic Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11	CI
Bangkok Lab and Cosmetic Public Company Limited Declares Cash Dividend Payment for the Operating Period from 01 January 2023 to 30 June 2023, Payable on 14 September 2023	15/23/15	CI
Bangkok Lab And Cosmetic Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Bangkok Lab And Cosmetic Public Company Limited has completed an IPO in the amount of THB 1.575 billion.	20/23/20	CI
Bangkok Lab And Cosmetic Public Company Limited has filed an IPO.	25/22/25	CI

Chart Bangkok Lab And Cosmetic

Duration

Period

More charts

Company Profile

Bangkok Lab and Cosmetic Public Company Limited is a Thailand-based producer and researcher of health products. The principal activities of the Company and subsidiaries are engaged in the manufacturing and distributing of pharmaceuticals and medicinal chemical products for humans and animals. It operates through pharmaceuticals and medicinal chemical products segment. Its products include ZENZERA 200 SUSPENSION, ZENZERA, SYNOVAR UC40, RADIARA, PROCEMINE, FANGO-B, EMBLICOF COUGH MIXTURE, CLINIGEL STERILE, RAQUA FIBROTA, RAQUA COLLAGEN, SYNOVAR UC, SYNOVAR POWDER, NACOXIB, LUTI-BERRY MIXED, ZIGA GEL (orange), ZERTINE SYRUP, VIZO Cream, SPORAXYL CREAM, NORAPHEN, MURHINOL-250 SYRUP, NORFLOXYL 400, NOCID, MURHINOL-250 SYRUP, MUCOBROX, GYNOSTEN CREAM, and GYNOSTEN 500, AROTIKA COOL GEL, ALLERAX-FC, AROTIKA RUB LOTION (SPRAY), Calza c Dietary Supplement, Calza PLUS POWDER Dietary, Calza-750 TAB FC, and others. Its subsidiaries include Bangkok Drug Co., Ltd., and Pharma Alliance Co., Ltd.

Sector

Pharmaceuticals

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BANGKOK LAB AND COSMETIC	+3.91%	78.4M
ELI LILLY AND COMPANY	+56.86%	815B
NOVO NORDISK A/S	+43.90%	641B
JOHNSON & JOHNSON	-6.57%	352B
MERCK & CO., INC.	+17.32%	314B
ABBVIE INC.	+9.94%	303B
ASTRAZENECA PLC	+16.08%	242B
ROCHE HOLDING AG	+2.29%	224B
NOVARTIS AG	+13.96%	218B
AMGEN INC.	+7.98%	168B